How Pharma Stocks are Affected by Trump’s Tariff Threats
Antara Bhattacharyya
Pharma Stocks Face Investor Jitters: Trump’s tariff threats have triggered uncertainty, making investors cautious and pushing pharma stocks into volatile territory.
Rising Import Costs Hit Margins: Tariffs on raw materials from China could inflate costs, reducing profit margins for leading pharmaceutical companies.
Supply Chain Disruptions Loom: Global pharma supply chains risk disruption, potentially delaying drug production and affecting availability in key markets.
Export Challenges for Indian Pharma: Indian pharmaceutical exports to the U.S. may see reduced competitiveness, pressuring major players in generics manufacturing.
Long-Term Industry Outlook Clouded: While demand remains strong, prolonged tariff disputes could reshape global pharma strategies and investor confidence.